Evotec International Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 472

Employees

  • Latest Deal Type
  • Corporate

  • Latest Deal Amount
  • $257K

Evotec International General Information

Description

Manufacturer of biopharmaceutical products. The company develops therapies for metabolic disorders based on model organisms and stem cell expertise.

Contact Information

Website
evotecoai.com
Formerly Known As
DeveloGen
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Marie-Curie-Strasse 7
  • 37079 Gottingen
  • Germany
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Corporate Office
  • Marie-Curie-Strasse 7
  • 37079 Gottingen
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Evotec International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Corporate 24-Jan-2012 $257K Completed Generating Revenue
5. Merger/Acquisition 03-Sep-2010 Completed Generating Revenue
4. Grant 23-Feb-2010 Completed Generating Revenue
3. Early Stage VC 17-May-2004 Completed Generating Revenue
2. Early Stage VC 18-Apr-2001 $35.6M $38.6M Completed Startup
1. Early Stage VC 01-Dec-1997 $3M $3M Completed Product Development
To view Evotec International’s complete valuation and funding history, request access »

Evotec International Patents

Evotec International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026209601-A1 Nlrp3 modulators Pending 31-Mar-2025
WO-2026131684-A1 Low-dose x-ray irradiation for the elimination of unwanted cell growth in pluripotent stem cell-derived islet-like clusters Pending 16-Dec-2024
WO-2026114926-A1 Prodrugs of nlrp3 modulators Pending 29-Nov-2024
WO-2026046953-A1 Methods of pluripotent stem cell expansion Pending 28-Aug-2024
EP-4684808-A1 Plasmids, transgenes, vectors and medical uses comprising adamts13 Pending 22-Jul-2024 A61K48/005
To view Evotec International’s complete patent history, request access »

Evotec International Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evotec International Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Allianz Specialized Investments Venture Capital Minority
Atlas Venture Venture Capital Minority
Aventis Corporation Minority
CBG Commerz Beteiligungskapital Mezzanine Minority
Carlyle AlpInvest PE/Buyout Minority
You’re viewing 5 of 16 investors. Get the full list »

Evotec International Acquisitions (1)

Evotec International’s most recent deal was a Merger/Acquisition with Peptor for . The deal was made on 17-May-2004.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Peptor 17-May-2004 Merger/Acquisition Biotechnology
To view Evotec International’s complete acquisitions history, request access »

Evotec International Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
NephThera Hamburg, Germany 2019

Evotec International FAQs

  • When was Evotec International founded?

    Evotec International was founded in 1997.

  • Where is Evotec International headquartered?

    Evotec International is headquartered in Gottingen, Germany.

  • What is the size of Evotec International?

    Evotec International has 472 total employees.

  • What industry is Evotec International in?

    Evotec International’s primary industry is Drug Discovery.

  • Is Evotec International a private or public company?

    Evotec International is a Private company.

  • What is the current valuation of Evotec International?

    The current valuation of Evotec International is .

  • What is Evotec International’s current revenue?

    The current revenue for Evotec International is .

  • How much funding has Evotec International raised over time?

    Evotec International has raised $257K.

  • Who are Evotec International’s investors?

    Allianz Specialized Investments, Atlas Venture, Aventis, CBG Commerz Beteiligungskapital, and Carlyle AlpInvest are 5 of 16 investors who have invested in Evotec International.

  • When was Evotec International acquired?

    Evotec International was acquired on 24-Jan-2012.

  • Who acquired Evotec International?

    Evotec International was acquired by Evotec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process